Get started
RocketTickers

Vertex Announces Positive Results From Phase 2 Study of VX-147 i

Long
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)  
RocketTickers  
NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
Beyond Technical Analysis
0
0
beyondta
VRTX: Vertex Pharmaceuticals Incorporated
2021-12-01 07:30:00
Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.